Filing Details
- Accession Number:
- 0000899243-19-028374
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-02 20:57:29
- Reporting Period:
- 2019-12-02
- Accepted Time:
- 2019-12-02 20:57:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1042418 | Inhibitor Therapeutics Inc. | INTI | Services-Commercial Physical & Biological Research (8731) | 541641133 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1510349 | J. Garrison Hasara | 4830 W. Kennedy Blvd., Suite 600 Tampa FL 33609 | Cfo And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-12-02 | 13,500 | $0.07 | 3,972,544 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at a per share price equal to $0.07 and $0.068. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.